Frazier Life Sciences Management, L.P. Hille Vax, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Hille Vax, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 10,617,062 shares of HLVX stock, worth $19.7 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
10,617,062
Previous 10,617,062
-0.0%
Holding current value
$19.7 Million
Previous $154 Million
87.83%
% of portfolio
1.01%
Previous 9.05%
Shares
4 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.8MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA4.92MShares$9.15 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.89 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.64 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.5 Million0.06% of portfolio
-
Carlyle Group Inc. Washington, DC1.84MShares$3.42 Million0.49% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $62.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.